{
  "ticker": "UNH",
  "target_date": "2025-05-21",
  "actual_date": "2025-05-21",
  "collected_at": "2025-12-08T11:47:42.317775",
  "price": {
    "open": 297.0,
    "high": 305.85,
    "low": 296.09,
    "close": 298.958251953125,
    "volume": 45506900,
    "change_1d_pct": -5.78,
    "change_7d_pct": -20.01,
    "change_30d_pct": -45.22
  },
  "technicals": {
    "rsi_14": 25.81,
    "sma_20": 362.4,
    "sma_50": 451.66,
    "macd": -46.459,
    "macd_signal": -43.036,
    "macd_histogram": -3.423,
    "bb_upper": 461.32,
    "bb_lower": 263.49,
    "price_vs_sma20_pct": -17.51,
    "price_vs_sma50_pct": -33.81,
    "volume_ratio": 1.64
  },
  "fundamentals": {
    "market_cap": 295339163648,
    "pe_ratio": 16.990072,
    "forward_pe": 10.904331,
    "price_to_book": 3.083845,
    "price_to_sales": 0.6786925,
    "profit_margin": 4.04,
    "operating_margin": 3.81,
    "roe": 17.48,
    "roa": 5.36,
    "revenue_growth": 12.2,
    "earnings_growth": -60.2,
    "debt_to_equity": 75.734,
    "current_ratio": 0.823,
    "quick_ratio": 0.745,
    "dividend_yield": 267.0,
    "fifty_two_week_high": 606.36,
    "fifty_two_week_low": 234.6,
    "fifty_day_avg": 342.1196,
    "two_hundred_day_avg": 361.9156,
    "analyst_target": 388.52,
    "analyst_recommendation": "buy",
    "num_analysts": 25,
    "sector": "Healthcare",
    "industry": "Healthcare Plans",
    "pct_from_52w_high": -46.23,
    "pct_from_52w_low": 38.98
  },
  "macro": {
    "spy": {
      "price": 579.54,
      "change_1d_pct": -1.69,
      "change_7d_pct": -0.68
    },
    "vix": {
      "level": 20.87,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.6
    },
    "dollar_index": {
      "level": 99.56
    },
    "gold": {
      "price": 3309.3
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q1 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1747865679,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e27504393d6270f71f4779aed94b422dee3a3fcabc889d6582ddb2468c20c3d3"
    },
    {
      "headline": "UnitedHealth, Humana, CVS drop on expanded Medicare Advantage audits",
      "source": "Yahoo",
      "datetime": 1747862046,
      "summary": "Investing.com -- Shares of major health insurers UnitedHealth (NYSE:UNH), Humana (NYSE:HUM), and CVS (NYSE:CVS) fell sharply today, with UnitedHealth down 4%, Humana declining 5%, and CVS dropping 4% in afterhours trading. The slide came in response to the Centers for Medicare & Medicaid Services (C",
      "url": "https://finnhub.io/api/news?id=019a4060e3276a5955707542ef6fc142269365b3f315c93a0304fea59c29ce12"
    },
    {
      "headline": "Why UnitedHealth Stock Sank Again Today",
      "source": "Yahoo",
      "datetime": 1747861148,
      "summary": "\"The Guardian\" is reporting that UnitedHealth was secretly offering bonuses to nursing homes to reduce their hospital transfers.  Shares of UnitedHealth Group (NYSE: UNH) plummeted again on Wednesday.  The company's stock is down 5.8% as of market close, while the S&P 500 (SNPINDEX: ^GSPC) and the N",
      "url": "https://finnhub.io/api/news?id=a741c9c8bbaaf05f76dd04eb05e6c928014d1ff2a6dcc32fa33df3da2fdcf8ef"
    },
    {
      "headline": "Wolfe Research Sees Margin Recovery As Key Catalyst for Unitedhealth (UNH)",
      "source": "Yahoo",
      "datetime": 1747858784,
      "summary": "Despite the company\u2019s recent setbacks, Wolfe Research analyst Justin Lake reiterated his bullish view on UnitedHealth Group Inc. (NYSE:UNH). While maintaining his Outperform rating, he lowered his price target to $390 from $501, driven by downward revisions of his earnings estimates as the company w",
      "url": "https://finnhub.io/api/news?id=c359aefddfb6eac93ca2d49057191e0f68ede2fcad25e8b4681b77f398714854"
    },
    {
      "headline": "Why UnitedHealth (UNH) Stock Is Nosediving",
      "source": "Yahoo",
      "datetime": 1747858179,
      "summary": "Shares of health insurance company UnitedHealth (NYSE:UNH) fell 5.5% in the afternoon session after HSBC analysts downgraded the stock's rating from Neutral to Sell, adding that the recent sell-off had yet to provide a cheap opportunity to buy. The analysts also cited key reasons for the concerns, i",
      "url": "https://finnhub.io/api/news?id=983136016f07314de17316f7bf069ed30d64485b85741ee2e1077bdcf040bb30"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "8-K",
      "date": "2025-05-21",
      "description": "unh-20250520.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/731766/000073176625000150/unh-20250520.htm"
    },
    {
      "form": "4",
      "date": "2025-05-16",
      "description": "xslF345X05/wk-form4_1747433501.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/731766/000073176625000146/xslF345X05/wk-form4_1747433501.xml"
    },
    {
      "form": "4",
      "date": "2025-05-16",
      "description": "xslF345X05/wk-form4_1747433498.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/731766/000073176625000145/xslF345X05/wk-form4_1747433498.xml"
    },
    {
      "form": "4",
      "date": "2025-05-16",
      "description": "xslF345X05/wk-form4_1747412895.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/731766/000073176625000142/xslF345X05/wk-form4_1747412895.xml"
    },
    {
      "form": "4",
      "date": "2025-05-16",
      "description": "xslF345X05/wk-form4_1747412624.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/731766/000073176625000141/xslF345X05/wk-form4_1747412624.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}